4//SEC Filing
SHALLCROSS STEVEN A 4
Accession 0001104659-23-126396
CIK 0000894158other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:07 PM ET
Size
5.9 KB
Accession
0001104659-23-126396
Insider Transaction Report
Form 4
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
- Award
Stock Options (right to buy)
2023-12-14+700,000→ 700,000 totalExercise: $0.59From: 2024-01-14Exp: 2030-12-14→ Common Stock (700,000 underlying)
Footnotes (1)
- [F1]These stock options vest pro rata on a monthly basis over 36 months.
Documents
Issuer
Theriva Biologics, Inc.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001263501
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:07 PM ET
- Size
- 5.9 KB